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Human migration and the spread of 
malaria parasites to the New World
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Júlio César de Souza Jr6,7, Zelinda M. B. Hirano6,7, Marina G. Bueno8, José Luiz Catão-Dias8, 
Rosely S. Malafronte9, Simone Ladeia-Andrade10, Toshihiro Mita11, Ana Maria Santamaria12, 
José E. Calzada12, Indah S. Tantular13, Fumihiko Kawamoto14, Leonie R. J. Raijmakers15,  
Ivo Mueller16,17, M. Andreina Pacheco18, Ananias A. Escalante18, Ingrid Felger19,20 &  
Marcelo U. Ferreira1
We examined the mitogenomes of a large global collection of human malaria parasites to explore 
how and when Plasmodium falciparum and P. vivax entered the Americas. We found evidence of a 
significant contribution of African and South Asian lineages to present-day New World malaria parasites 
with additional P. vivax lineages appearing to originate from Melanesia that were putatively carried 
by the Australasian peoples who contributed genes to Native Americans. Importantly, mitochondrial 
lineages of the P. vivax-like species P. simium are shared by platyrrhine monkeys and humans in the 
Atlantic Forest ecosystem, but not across the Amazon, which most likely resulted from one or a 
few recent human-to-monkey transfers. While enslaved Africans were likely the main carriers of P. 
falciparum mitochondrial lineages into the Americas after the conquest, additional parasites carried by 
Australasian peoples in pre-Columbian times may have contributed to the extensive diversity of extant 
local populations of P. vivax.
The Americas were the last continent to be settled by modern humans. Approximately 15,000 years ago, the first 
Americans crossed the land bridge that connected Siberia to Alaska in the late Pleistocene. The precise date of the 
earliest arrival, number of founding events, and precise geographic source of peoples who migrated to the New 
World remain uncertain1.
These early migrants are unlikely to have carried malaria parasites through the cold and arid route to Alaska2,3. 
Accordingly, present-day Native Amerindians do not show genetic traits conferring protection from malaria 
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infection or severity, such as hemoglobinopathies, sickle-cell trait, glucose-6-phosphate dehydrogenase (G6PD) 
deficiency, and Duffy antigen/receptor for chemokines (DARC) negativity, which have been selected in African 
and Eurasian populations heavily exposed to malaria4. Moreover, reports of conquerors and early settlers fail 
to mention severe malaria-like illnesses in indigenous populations soon after European contact5–7. Therefore, 
the most virulent human malaria parasite, Plasmodium falciparum, most likely entered the New World after 
European contact and was carried by Africans brought to the Americas between the mid-1500s and mid-1800s8 
and settlers from the main colonizing nations, Portugal and Spain, where malaria was endemic at the time of 
conquest9,10.
How and when the less deadly species P. vivax arrived in the New World remains controversial. This parasite 
was endemic to southern Europe until the mid-1900s9,10, but it was rare in West and Central Africa, the origin 
of most enslaved peoples displaced to the Americas. Nearly all of them lack DARC, a key receptor for red blood 
cell invasion by P. vivax, and are therefore virtually resistant to blood-stage infection with this species11. Parasites 
may also have entered the New World in pre- and post-Columbian times with migrants from the Asian main-
land and the Western Pacific3,12,13, further contributing to the surprisingly high genetic diversity of P. vivax in 
the Americas14–17. Archaeological evidence for infection with P. vivax in pre-Columbian Native Americans is 
currently limited to a single report of species-specific antigens visualized by immunohistochemistry in South 
American mummies dating from 3,000 to 600 years ago18, but confirmation of P. vivax infection with more spe-
cific molecular techniques is still required19. Importantly, specific antibodies failed to detect P. falciparum antigens 
in these same samples18.
Here, we analyze a large global sample of mitochondrial genomes (mitogenomes) to test competing hypoth-
eses about the geographic origins of New World human malaria parasites2,7,13,20–22. We search for signatures of 
ancestral source populations in isolates of P. falciparum and P. vivax currently circulating in the Americas and of 
a P. vivax-like species, P. simium, which infects platyrrhine monkeys of the Atlantic Forest of South and Southeast 
Brazil. We find significant gene flow from Africa and South Asia to New World populations of malaria para-
sites with some additional genetic contribution of Melanesian lineages to local P. vivax strains. Because of the 
low diversity of P. simium lineages circulating in monkeys and humans in the Atlantic Forest ecosystem com-
pared with P. vivax strains from across the country, we argue for a recent human-to-monkey transfer of these P. 
vivax-like parasites.
Results
Global and regional diversity of malaria parasite mitogenomes. Overall, we found less mitochon-
drial DNA diversity in P. falciparum than in P. vivax populations worldwide (Table 1; Supplementary Tables 1 and 2). 
We identified 330 single-nucleotide polymorphisms (SNPs) and 325 unique haplotypes in 1,795 mitogenomes 
from six regional P. falciparum populations, namely, populations in Africa (AFR), South America (SAM), Central 
America (CAM), South Asia (SOA), Southeast Asia (SEA), and Melanesia (MEL). The 941 mitogenomes from 
P. vivax populations in AFR, SAM, CAM (including Mexico), Middle East and Central Asia combined (MCA), 
SOA, SEA, East Asia (EAS), and MEL comprised 348 SNPs and 405 unique haplotypes.
Geographic subdivisions in worldwide malaria parasite populations. Bayesian phylogenetic analy-
sis revealed a clear geographic structure in the global P. falciparum population (Fig. 1A), which is consistent with 
independent regional colonization events23,24. The vast majority (81.0%) of SAM samples (n = 237) cluster in one 
of three well-supported clades (posterior probability > 0.7), each comprising a single haplotype. Two of these 
clades, Ame1 (157 samples from SAM [Brazil, Venezuela, Peru, and Ecuador] and 1 from AFR) and Ame2 (22 
samples from SAM [all from Brazil]), are closely related to each other, as indicated by their single-step connection 
in the median-joining network shown in Fig. 1B. The third clade comprising SAM samples, Global1, is the largest 
one in the phylogeny with 450 samples from all regions (263 from AFR, 129 from MEL, 29 from SEA, 15 from 
SOA, 13 from SAM [all from Brazil], and 1 from CAM). Interestingly, the partial mitochondrial genome retrieved 
Regional 
population




No. P. vivax 
isolates
Nucleotide diversity
Hd (SD)bπa (SD)b θsc (SD)b πa (SD)b θsc (SD)b
AFRe 629 0.00026 (0.00001) 0.00486 (0.00094) 0.775 (0.014) 90 0.00043 (0.00005) 0.00254 (0.00068) 0.7930 (0.047)
CAMf 8 0.00035 (0.00007) 0.00027 (0.00017) 0.857 (0.108) 68 0.00008 (0.00002) 0.00040 (0.00015) 0.3510 (0.076)
EASg — — — — 125 0.00082 (0.00005) 0.00121 (0.00034) 0.9170 (0.015)
MCAh — — — — 30 0.00060 (0.00008) 0.00126 (0.00044) 0.9490 (0.023)
MELi 308 0.00028 (0.00002) 0.00113 (0.00028) 0.740 (0.019) 128 0.00045 (0.00005) 0.00178 (0.00047) 0.8669 (0.023)
SAMj 237 0.00018 (0.00002) 0.00160 (0.00039) 0.551(0.039) 238 0.00058 (0.00030) 0.00330 (0.00075) 0.9291 (0.012)
SEAk 532 0.00028 (0.00001) 0.00139 (0.00031) 0.773 (0.015) 160 0.00087 (0.00003) 0.00280 (0.00068) 0.9700 (0.006)
SOAl 81 0.00036 (0.00004) 0.00094 (0.00029) 0.858 (0.027) 102 0.00055 (0.00005) 0.00255 (0.00067) 0.9440 (0.018)
Total 1795 0.00036 (0.00002) 0.00708 (0.00118) 0.887 (0.0047) 941 0.00085 (0.00002) 0.00807 (0.00014) 0.9732 (0.0027)
Table 1. Global and regional levels of genetic diversity in Plasmodium falciparum and P. vivax mitogenomes. 
aπ = average number of pairwise nucleotide differences per site; bSD = standard deviation; cθS = standardized 
number of segregating sites; dH = haplotype diversity; eAFR = Africa; fCAM = Central America; gEAS = East 
Asia (only P. vivax); hMCA = Middle East and Central Asia (only P. vivax); iMEL = Melanesia; jSAM = South 
America; kSEA = Southeast Asia; and lSOA = South Asia.
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from an old European sample of P. falciparum25 is two mutational steps away from the Global1 haplotype; it is 
shared by three SOA isolates, but not SAM samples (Fig. 3 of Gelabert and colleagues25). Most (57.8%) African 
lineages have the Global1 and Global2 haplotypes with the latter comprising 146 samples (133 from AFR, 9 from 
SOA, 3 from SEA, and 1 from SAM [Brazil]). Haplotypes Global1 and Global2 have a single-step connection to 
each other, whereas the most common South American haplotype, Ame1, is only one mutational step away from 
Global2 and two steps away from Global1 (Fig. 1B). SAM shares 5 haplotypes with other populations, and 4 of 
them with AFR (Supplementary Table 3). The relative genetic proximity between SAM and AFR mitochondrial 
lineages compared with those from other regions suggests that AFR is a major source of extant South American 
populations of P. falciparum. The origin of CAM lineages cannot be inferred from our phylogeny because 7 of the 
8 CAM mitogenomes are placed in the undifferentiated cluster in the center of the tree (Fig. 1A).
Estimates of the Wright’s fixation index (FST), a measure of divergence between populations due to genetic 
structure, revealed substantial genetic differentiation across regional populations of P. falciparum. All FST values 
were significantly different from zero, and 11 of the 15 pairwise comparisons yielded FST values > 0.15, which is 
consistent with relatively little gene flow between populations. SAM is the most divergent P. falciparum popula-
tion with FST = 0.468 in the comparison with AFR and FST > 0.50 in all other comparisons with regional popu-
lations (Supplementary Table 4). P. falciparum mitochondrial lineages from AFR, however, show relatively little 
differentiation from SOA (FST = 0.091) and MEL (FST = 0.130).
South American mitochondrial lineages of P. vivax are widely spread across the Bayesian phylogenetic tree 
(Fig. 2A). Three well-supported clades (posterior probability > 0.7) comprise 47.5% of the 238 SAM samples: 
Ame1 (58 identical haplotypes from SAM, 54 from CAM, 1 from SOA, and 2 from MEL), Ame2 (25 lineages from 
SAM and 2 from SEA), and Atl (30 lineages from the Atlantic Forest of Brazil). Most remaining SAM lineages are 
placed in the central, star-shaped component of the tree. In contrast, the vast majority (85.3%) of the 68 CAM 
samples cluster in a single clade, Ame1. Three additional CAM samples (but none from SAM) have the Afr1 hap-
lotype, which is shared by AFR (n = 40), SOA (n = 25), and MCA (n = 2) samples (Fig. 2B). Only 3 (2.5%) of the 
119 haplotypes circulating in SAM are shared with other regional populations (CAM, SOA, SEA, and MEL), and 
none of them are shared with AFR (Supplementary Table 5).
The only currently available, partially sequenced P. vivax mitochondrial lineage from Europe is very close to 
Ame1 (Fig. 2 of Gelabert and colleagues25). Interestingly, the Ame1 haplotype occupies a central position in the 
median-joining network representing New World P. vivax lineages (Supplementary Fig. 1). Indeed, Ame1 has 
single-step connections with haplotypes Afr1 (shared by 44.5% of AFR and 24.5% of SOA samples and a few CAM 
and MCA lineages), Mel1 (shared by 30.5% of MEL samples), Sea1 (shared by SEA, SOA, and MEL samples), 
and Sea2 (shared mostly with SEA but also with CAM and SAM samples [two of each]; Fig. 2B). Ame1 has been 
hypothesized to be of European origin, but it is directly related to the original (putatively now extinct) African 
population, and it is ancestral to regional lineages, such as Mel1, Sea1, and Sea226. Interestingly, nine mitochon-
drial lineages of P. vivax-like parasites previously recovered from great apes in Central Africa27 did not cluster 
together with human parasites from this continent. Instead, they are only 2–4 mutational steps away from the 
Ame1 haplotype circulating in the New World (Supplementary Fig. 3), which is again consistent with the notion 
that present-day New World lineages are most closely related to original African parasites26.
Wright’s FST values > 0.15 were found in 24 of the 28 pairwise comparisons of regional P. vivax populations 
(Supplementary Table 6). Relatively little (although significant) genetic differentiation can be found between AFR 
and SOA (FST = 0.014), AFR and MCA (FST = 0.087), and SOA and MCA (FST = 0.075), which is consistent with 
Figure 1. Bayesian phylogenetic tree (A) and median-joining network (B) of the global sample of Plasmodium 
falciparum mitochondrial lineages (n = 1795). Circle sizes in B are proportional to haplotype frequencies, and 
pairs of haplotypes connected by a straight line differ by a single mutational step. The following color code was 
used to identify the geographic origin of parasites: red = Africa, dark blue = South America, light blue = Central 
America, orange = South Asia, green = Southeast Asia, and pink = Melanesia. Branches with posterior 
probabilities >0.70 are indicated by black circles in the phylogenetic tree; selected well-supported clades 
indicated in the figure (Ame1, Ame2, Global1, and Global2) are further discussed in the main text.
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the hypothesis of recolonization of AFR following the near fixation of DARC negativity in local human popula-
tions by P. vivax stocks from the Middle East and SOA3,26.
Interestingly, gene flow patterns across continents appear to differ markedly according to parasite spe-
cies (Supplementary Tables 4 and 6). For example, the MEL population of P. vivax is less divergent from SAM 
(FST = 0.242) than it is from AFR, SOA, or SEA (FST between 0.320 and 0.406); in contrast, the MEL population 
of P. falciparum is very divergent from SAM (FST = 0.558), but not as divergent from AFR, SOA, or SEA (FST 
between 0.097 and 0.130). Therefore, FST estimates provide some evidence of gene flow between MEL and SAM 
populations of P. vivax–a finding to be further explored in subsequent analyses–but very little gene flow between 
the corresponding populations of P. falciparum.
Thirty-two P. vivax/P. simium lineages from humans and platyrrhine monkeys from forest-covered areas along 
the Atlantic Coast of Brazil have been included in our phylogenetic analysis. These ATL samples (represented in 
yellow in Fig. 2A,B; see also Fig. 3) originate from sites >2,000 km away from the Amazon Basin (Supplementary 
Fig. 2), the main P. vivax-endemic area in this country. They comprise P. simium isolates collected within a radius 
of 440 km from nine brown howler monkeys (Alouatta clamitans) and one black-fronted titi monkey (Callicebus 
nigrifrons) and P. vivax samples from 22 human infections within a radius of 40 km in the southeastern state 
of Espírito Santo (Supplementary Table 7). Regardless of their host, 30 of 32 ATL samples cluster in clade Atl 
(which contains two main haplotypes, Atl1 and Atl2), whereas two human samples from Espírito Santo have the 
Ame1 haplotype (Fig. 2A,B). Importantly, the time to the most recent common ancestor (TMRCA) of the entire 
Atl clade, which is estimated at 23,440 years before present (95% highest probability density [HPD] interval, 
16,164–29,879 years before present), precedes the most likely dates of P. vivax arrival in the Americas. Nine of 
10 P. simium samples share the Atl1 haplotype, which is also found in 5 P. vivax samples recovered from humans 
living 700-1,500 km north of the P. simium collection sites (Fig. 3 and Supplementary Table 7). The Atl2 haplo-
type, which was recovered from the original Fonseca MRA-353 isolate collected in the mid-1960s in São Paulo, is 
shared by 9 human P. vivax samples collected in Espírito Santo (over 700 km north of São Paulo) in the early 2000s 
(Supplementary Table 7) and by three patients from Rio de Janeiro28. The two human samples from the Atlantic 
Forest with the Ame1 haplotype were most likely imported from the Amazon Basin. Importantly, however, the 
Atl1 and Atl2 lineages that circulate in humans and platyrrhine monkeys in south and southeast Brazil–and 
differ from each other by the A3325T nucleotide substitution at the cox1 locus–have no clear connection with P. 
vivax populations from other continents (Fig. 2A,B). Two private SNPs mapping to the cox1 gene (T4134C and 
A4468G) show potential for distinguishing autochthonous and potentially zoonotic P. vivax infections from the 
Atlantic Forest of Brazil from those imported from the Amazon Basin or elsewhere (Supplementary Table 8).
Figure 2. Bayesian phylogenetic tree (A) and median-joining network (B) of the global sample of Plasmodium 
vivax mitochondrial lineages (n = 941). Circle sizes in B are proportional to haplotype frequencies, and pairs 
of haplotypes connected by a straight line differ by a single mutational step. The following color code was used 
to identify the geographic origin of parasites: red = Africa, dark blue = South America, light blue = Central 
America and Mexico, yellow = Atlantic Forest from southeast and South Brazil, brown = Middle East and 
Central Asia, orange = South Asia, green = Southeast Asia, dark purple = East Asia, and pink = Melanesia. 
Branches with posterior probabilities >0.70 are indicated with black circles in the phylogenetic tree; selected 
well-supported clades indicated in the figure (Ame1, Ame2, Atl, Afr1, Mel1, Sea1, and Sea2) are further 
discussed in the main text.
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Demographic history and divergence time. Several findings suggest a past demographic expansion of 
human malaria parasites worldwide. First, both Tajima’s and Fu’s tests yielded significantly negative values for 
most regional populations of P. falciparum, except for CAM and SOA (for the latter, only Tajima’s D test result was 
significantly negative), and P. vivax, except for SAM, MCA (only Tajima’s D test results were significantly negative 
for both) and EAS (Table 2). Likewise, separate country-specific analyses yielded significantly negative Tajima’s 
and Fu’s test values for P. falciparum populations from Brazil and Venezuela (Supplementary Table 9) and P. vivax 
populations from Brazil, Colombia, and Peru (Supplementary Table 10). In addition, the frequency distributions 
of pairwise nucleotide mismatches in mitochondrial sequences fit those expected under a sudden demographic 
expansion model for most regional populations of P. falciparum, except for AFR and SOA (Supplementary 
Fig. 4 and Supplementary Table 11), and all populations of P. vivax (Supplementary Fig. 5 and Supplementary 
Table 11). Evidence for demographic expansion was further obtained in country-specific mismatch distribution 
analyses of SAM populations of P. falciparum (Supplementary Fig. 6 and Supplementary Table 12) and P. vivax 
(Supplementary Fig. 7 and Supplementary Table 12).
Moreover, Bayesian skyline analysis revealed evidence of a past P. falciparum population expansion world-
wide between 25,000 and 10,000 years ago (Supplementary Fig. 8). Likewise, the global P. vivax population has 
expanded exponentially between 30,000 and 10,000 years before present (Supplementary Fig. 9). Evidence for 
past demographic expansions has also been found for the SAM population of both P. falciparum and P. vivax, but 
not for the CAM population of P. vivax (Supplementary Figs 10 and 11). Interestingly, neither P. falciparum nor 
P. vivax SAM populations show evidence of a decline in effective population size following their relatively recent 
arrival in the New World. In fact, present-day malaria parasites from this continent display clear signatures of 
expansion approximately 10,000–25,000 years ago; this expansion was experienced by the ancestral populations 
from which they have derived more recently (Supplementary Figs 10 and 11).
The TMRCA estimates for SAM populations of P. falciparum (37,002 years; 95% HPD interval, 21,385–56,606 
years before present) and P. vivax (52,149 years; 95% HPD interval, 29,896–60,659 years before present) indicate 
that the hypothetical most recent common ancestor of New World malaria parasites largely predates the first 
human migrations to the continent. Moreover, these estimates are rather similar to those obtained for popula-
tions of AFR P. falciparum (35,384 years; 95% HPD interval, 21,101–54,974 years before present) and P. vivax 
(41,685 years; 95% HPD interval, 28,630-57,563 years before present). Therefore, skyline analysis and TMRCA 
estimates argue against a severe population bottleneck associated with the recent malaria parasite migration to 
the Americas (see also14); to the contrary, SAM lineages appear to have retained much of the diversity that preex-
isted in their ancestral populations.
Parasite migration models. We used a Bayesian approach29 to estimate median mutation-scaled pairwise 
migration rates (M) and compare a priori parasite migration models. These models treat SAM and CAM as a 
single American population (“SAM and CAM combined”). The basic models assume an African origin of malaria 
parasites and subsequent eastward spread to Asia and MEL with separate westward migration from AFR to the 
Americas. However, models differ according to the potential genetic contribution of regional parasite populations 
(other than the African population) to New World populations of P. falciparum and P. vivax. The best-supported 
P. falciparum model (C1, which has a posterior probability of 0.75; Supplementary Fig. 12 and Supplementary 
Table 13) assumes gene flow mostly from AFR (median M = 1380.0) but also from SOA (median M = 740.0) to 
the Americas with intense bilateral gene flow between the AFR and SOA populations; no further genetic contri-
bution to American lineages was observed from other regional populations (Fig. 4A). Model A1, which assumes 
gene flow to the New World from AFR, but not from SOA, is moderately supported (posterior probability = 0.24).
The P. vivax a priori migration models treated MCA and SOA as a single population (SOA*) and included 
Plasmodium vivax/P. simium samples from the Atlantic Forest in the American population (SAM and CAM com-
bined). The best-supported P. vivax model assuming an African origin of P. vivax (F, which has a posterior proba-
bility of 0.92; Supplementary Fig. 13 and Supplementary Table 14), similar to the top P. falciparum model, allows 
Population
P. falciparum P. vivax
Tajima’s D P value Fu’s Fs P value Tajima’s D P value Fu’s Fs P value
AFRa −2.78152 <0.0001 −14.28997 <0.02 −2.73599 <0.0001 −6.32855 <0.02
CAMb 1.29320 0.889 −1.31251 <0.10 −2.14553 <0.0001 −4.08699 <0.02
EASc — — — — −0.98766 0.15 −1.74506 >0.10
MCAd — — — — −1.90704 0.01 −3.05478 <0.05
MELe −2.10716 0.003 −4.63388 <0.02 −2.32606 <0.0001 −4.11114 <0.02
SAMf −2.61638 <0.0001 −8.87358 <0.02 −2.53550 <0.0001 0.03668 >0.10
SEAg −2.21823 <0.0001 −6.27935 <0.02 −2.16371 <0.0001 −6.61222 <0.02
SOAh −1.89148 0.008 −2.88087 <0.05 −2.55500 <0.0001 −5.32889 <0.02
Total −2.68819 <0.0001 −18.2203 <0.02 −2.61983 0.001 −7.09593 <0.02
Table 2. Results of Tajima’s D and Fu’s Fs neutrality tests applied to global and regional populations of 
Plasmodium falciparum and P. vivax. Statistically significant P values are underlined. aAFR = Africa; 
bCAM = Central America (including Mexico in the P. vivax analyses); cEAS = East Asia (only P. vivax); 
dMCA = Middle East and Central Asia (only P. vivax); eMEL = Melanesia; fSAM = South America; 
gSEA = Southeast Asia; and hSOA = South Asia.
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unilateral gene flow to the New World from both AFR (median M = 246.7) and SOA* (median M = 153.3) and 
assumes bilateral gene flow between AFR and SOA*. However, in contrast to the P. falciparum migration mod-
els, this P. vivax model also assumes a unidirectional gene flow from MEL to the Americas (median M = 193.3; 
Fig. 4B). The next best supported model assuming an African origin of P. vivax (A1, with a posterior probability 
of 0.05) allows for gene flow to the New World only from AFR, not from SOA* (Supplementary Fig. 13 and 
Supplementary Table 14).
We also modeled an alternative scenario that assumes a Southeast Asian (instead of African) origin of P. vivax 
with subsequent eastward spread to EAS and MEL and westward migration to South Asia, AFR, and the Americas 
(Supplementary Fig. 14). The best-supported model assuming a Southeast Asian origin of P. vivax (B, which has a 
posterior probability of 0.99; Supplementary Table 15) also allows for gene flow to the New World from both AFR 
and MEL (median M = 246.7 for both; Fig. 4C).
Discussion
Mitogenomes to track the migration of malaria parasites. There are clear advantages to using 
the 6-kb mitogenome to track past migrations of malaria parasites. First, because the mitogenome is unipa-
rentally inherited through the female gamete, lineages do not recombine with each other and their genealogy 
can be resolved by phylogenetic analysis30. Moreover, mitochondrial SNPs appear to be evolutionarily neutral 
and enable an accurate description of the parasite’s demographic history14,31. Finally, since this genome can be 
easily sequenced with Sanger-based or next-generation sequencing methods, several hundreds of complete 
mitogenomes of P. vivax and P. falciparum collected worldwide are currently available in public databases. Some 
limitations, however, must be considered. First, mitogenomes provide little resolution for fine-scale studies of 
geographic polymorphism because of their relatively limited number of segregating sites. Second, because there 
is no recombination, mitochondrial sequence analysis provides a picture of a parasite′s single locus, which may 
not be representative of its entire genome. Third, our data violate some assumptions of the underlying coales-
cent model of migration analysis, such as high inbreeding and constant Ne and gene flow over time. Fourth, 
the assumed geographic origin of malaria parasites affects all other gene flow rates estimated by the models. 
Moreover, the undetermined genetic contribution from unsampled parasite populations (e.g., from Europe and 
other parts of AFR) may confound estimates of gene flow between sampled populations. Although simulation 
analyses suggest that coalescent-based migration models are very robust to biases introduced by small to mod-
erate violations of model assumptions that are usually seen in real-world populations32, we consider these model 
outputs to be a first glimpse at the complex demographic history of human malaria parasites.
Origins of Plasmodium falciparum circulating in the New World. Plasmodium falciparum is cur-
rently hypothesized to have originated from a lateral transfer from gorillas to humans in Western Africa between 
10,000 and 100,000 years ago33. From the African cradle, the parasite spread to Eurasia and the southwest Pacific 
as modern humans colonized these regions24, whereas a separate, massive human migration out of AFR brought 
P. falciparum to the New World8.
Figure 3. Median-joining network of Plasmodium vivax/P. simium mitochondrial lineages from the Atlantic 
Forest of Southeast and South Brazil. Circle sizes are proportional to haplotype frequencies, and pairs of 
haplotypes connected by a straight line differ by a single mutational step. Yellow indicates samples from 
monkeys, and blue indicates samples from humans. Haplotypes Atl1, Atl2, and Ame1 are indicated. Sample 
collection sites and dates, as well as their respective hosts, are listed in Supplementary Table 7; sample collection 
sites are plotted on a map in Fig. S2.
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More than 7 million enslaved Africans arrived in the Americas over three centuries. More than 2 million were 
disembarked at Spanish ports in the West Indies, Veracruz (Mexico), and Cartagena (Colombia), whereas nearly 
5 million were brought to the main Portuguese-run ports of Brazil, Recife, Salvador, and Rio de Janeiro34. Most 
slaves imported to Brazil throughout the 16th century came from the Upper Guinea Coast (present-day Senegal 
and Gambia). Angola and Congo became the major source of slaves in the late 16th century, complemented by 
the Mina Coast (Togo, Benin, and southwestern Nigeria) starting in the early 1700s and by southeastern Africa 
(Mozambique and Madagascar) from the end of the 18th century. Nearly 2 million Africans are estimated to have 
been brought to Brazil during the 18th century35. Enslaved Africans were captured not only along the coast, where 
major European outposts were located, but also in more distant Central or East African locations35.
Figure 4. Magnitude and directionality of historical gene flow between regional populations of Plasmodium 
falciparum (A) and P. vivax (B and C). Estimates of median mutation-scaled pairwise migration rates obtained 
with the best-supported migration model for each species are shown next to the arrows. Migration models 
tested are described in Supplementary Fig. 13 and compared in Supplementary Tables 14 and 15; the major 
difference between the models shown in B and C is that the former assumes an out-of-Africa spread of P. vivax, 
whereas the latter assumes a Southeast Asian origin of this parasite. The geographic origins of mitochondrial 
lineages are indicated on the map at the country level using the same color code as those of Fig. 1 (for P. 
falciparum) and Fig. 2 (for P. vivax) to represent geographic regions. Maps were built using the open-access R 
software library rworldmap: mapping global data combined with the ggplot2 library, which are both available at 
http://www.R-project.org/ (R Core Team, R: A Language and Environment for Statistical Computing.Vienna, 
Austria: R Foundation for Statistical Computing, 2017).
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Therefore, P. falciparum lineages introduced by slave trade into the Americas originated from a wide variety of 
African locations and resulted in additional genetic contribution, as suggested by the best-supported migration 
model of SOA migrants crossing the Indian Ocean to coastal areas and islands (e.g., Madagascar) of Southeast 
Africa (Fig. 4A). The lack of an apparent bottleneck in South American populations of P. falciparum is somewhat 
surprising. Not only parasite migration events, but also selective sweeps induced by large-scale antimalarial use in 
more recent years could have drastically reduced parasite diversity in this continent. We argue, however, that the 
current diversity levels have originated from the very many introductions of this parasite into the continent over 
centuries, from several different source populations in Africa. The substantial differentiation between present-day 
SAM and AFR lineages of P. falciparum likely results from the fact that we have not sampled all potential AFR 
source populations (Supplementary Fig. 15) or all P. falciparum subpopulations currently found in the Americas. 
Moreover, since not all migrants are expected to have successfully adapted to local vectors, the parasite popula-
tions currently found in the Americas are not expected to represent a random subsample of their multiple source 
populations. The relative contribution of European lineages to SAM and CAM populations of P. falciparum can-
not be estimated from our data because this potential source population remains largely unsampled.
Early human migration and the origins of P. vivax diversity in the New World. The extensive 
genetic diversity currently found in P. vivax populations in the Americas is consistent with successive migratory 
waves and subsequent admixture between parasites from different source populations14. Our data suggest that 
the extant lineages of AFR and SOA* populations represent major genetic contributors to current New World 
lineages of P. vivax (Fig. 4B); again, the relative contribution of European lineages remains undetermined.
Carter3 has speculated that a relapsing parasite such as P. vivax might have survived long-range, 
pre-Columbian oceanic crossings from the Western Pacific to the Americas through a reverse Kon-Tiki route. 
Accordingly, the best-supported P. vivax migration models assume a significant gene flow from MEL to the 
Americas (Fig. 4B,C) in addition to the expected genetic contribution from AFR and SOA* populations. Indeed, 
recent genome-wide analyses of human populations have revealed that at least three South American Native 
peoples – the Suruí, Karitiana, and Xavante – share more ancestry with indigenous populations from Australia, 
Melanesia, and island SEA than with Eurasians or other Native Americans36. These findings are consistent with 
two founding populations – one from Eurasia and one from Australasia – entering the Americas. This second 
founding population consisted of descendants of “population Y”, which is hypothesized to have contributed genes 
to both Australasians and Native Americans. Traces of Australasian ancestry were also independently found in 
the nuclear genomes of Aleutian islanders and Athabascans from North America and Suruí from Brazil37 and in 
the mitogenome of now-extinct Botocudo peoples from Brazil38.
One can hypothesize that descendants of population Y might have carried Melanesian strains of P. vivax to 
SAM (and possibly to the Amazon) long before the Europeans arrived, but could malaria parasites have sur-
vived in small, impermanent, and relatively isolated villages found in the Amazon in pre-Columbian times? This 
notion of a sparsely populated, pristine Amazon39 is contradicted by emerging evidence for the existence of large 
sedentary societies across this region that predated European conquest40–42. Evidence of these relatively complex 
societies has been found only 300–500 km away from the reserves where the Suruí and Karitiana peoples, who 
bear clear genetic traces of Australasian ancestry, currently live in the Western Amazon of Brazil43,44.
The P. simium puzzle. The evolutionary history of P. vivax is complex. This human lineage appears to have 
originated as part of the radiation of non-human primate malaria parasites that are now commonly found in 
SEA45. However, closely related parasites have been found to infect chimpanzees and gorillas in sub-Saharan 
Africa28,46, which is consistent with an early introduction of ancient parasite lineages into AFR that infected 
hominids and may have given rise to the human parasite species known as P. vivax. Surprisingly, a P. vivax-like 
parasite can also be found in New World platyrrhine monkeys, which diverged from African great apes and 
Old-World catarrhine monkeys more than 40 million years ago47. Plasmodium simium was originally described 
in non-human primates from São Paulo, southeast Brazil48, and subsequently found in two genera of the Atelidae 
family, howler monkeys (Alouatta caraya and A. clamitans) and woolly spider monkeys (Brachyteles arach-
noides)49. More recently, natural P. simium infections have also been described in capuchin monkeys (Cebus and 
Sapajus species of the Cebinae subfamily of the Cebidae family)50 and the black-fronted titi monkey Callicebus 
nigrifrons (Callicebinae subfamily of the Pitheciidae family)51 from the Atlantic Forest of Brazil.
Plasmodium simium is morphologically and genetically indistinguishable from P. vivax49,52,53, which is consist-
ent with one or more host switches between humans and monkeys in recent evolutionary times. The direction of 
the host switch (whether from monkeys to humans or vice-versa) remains under debate47,54, although available 
phylogenetic data renders a lateral transfer from New World monkeys to humans very unlikely31,55,56. By com-
paring levels of genetic diversity in P. vivax and P. simium populations from the Atlantic Forest, one can infer that 
the species with the greatest polymorphism is likely to be the ancestor47,54. Our findings strongly support a recent 
human-to-monkey transfer in Brazil, which is consistent with the low diversity of P. simium lineages recovered 
from monkeys living in three separate locations of this country (only two haplotypes found) compared with P. 
vivax strains from humans living in the Atlantic Forest ecosystem and in the Amazon.
Moreover, a comparison of newly available P. simium samples with worldwide P. vivax isolates allowed us to 
test further hypotheses about the geographic origin of the P. vivax-like parasites that currently infect monkeys 
in Brazil. Li and colleagues12 characterized genetic polymorphisms in the S-type of the 18S rRNA gene and the 
plastid genome that putatively distinguish Old World from New World lineages of P. vivax. Furthermore, they 
found that the Fonseca MRA-353 strain of P. simium carried the Old World-type sequence and speculated that P. 
simium and the P. vivax populations that currently circulate among humans in the Americas entered the continent 
on two separate occasions that were most likely from different source populations12. Cormier13 further hypoth-
esized that East Asian migrants might have introduced Old World P. vivax/P. simium lineages into the Atlantic 
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Coast of Brazil in the early 1800s. However, subsequent analyses revealed both New World and Old-World types 
of 18 S rRNA gene sequences in parasites from the Amazon Basin of Brazil and from Sri Lanka (Supplementary 
Text 1). Moreover, the P. simium lineages Atl1 and Atl2 do not cluster with Old World P. vivax populations in 
our phylogenetic analyses (Fig. 2A,B). We thus conclude that both Old World- and New World-type 18 S rRNA 
gene sequences are found in SAM and SOA and that P. simium mitogenomes are not closely related to Old World 
mitochondrial lineages of P. vivax.
Significantly, ATL parasites (including Atl1 and Atl2) are transmitted by anopheline mosquitoes of the 
Kerteszia subgenus, mainly Anopheles K. cruzi and An. K. bellator, which breed in water trapped by the leaf axils 
of bromeliad plants in the Atlantic Forest57. Conversely, P. vivax populations circulating among humans in the 
Amazon Basin are transmitted by members of Nyssorhynchus subgenus, mainly An. darlingi58. The adaptation 
to different local mosquito vectors may have favored the divergence between P. vivax lineages that have been 
brought to Brazil and currently circulate in distinct, non-contiguous endemic foci in the Amazon and along 
the Atlantic Coast. Accordingly, an example of genetically distinct P. vivax subpopulations being transmitted by 
different vectors has been described in southern Mexico59. We hypothesize that a few ATL lineages adapted to 
Kerteszia anophelines have been transferred to platyrrhine monkeys, favored by their vectors’ ability to bite both 
at the canopy of the trees (where monkeys live) and at the ground level (where humans are commonly found)49. 
The relative role of these zoonotic lineages as a source of human infections in coastal Brazil is a matter that 
requires further investigation in the context of ongoing malaria elimination efforts in the region28.
Materials and Methods
Ethics statement. Study protocols were approved by the Institutional Review Board of the Institute of 
Biomedical Sciences, University of São Paulo (protocol #1102), by the Institutional Review Board of the Papua 
New Guinea Institute of Medical Research (IRB 0919), and by the Government of Papua New Guinea Medical 
Research Advisory Committee (MRAC 09/24). Written informed consent was obtained from all adult patients, 
and minors (<18 years of age) had consent provided by a parent/guardian on their behalf. Monkey-derived blood 
samples were collected under the approval of the Brazilian Institute of Environment and Renewable Natural 
Resources (protocol #54173-1). All the methods were carried out in accordance with the approved guidelines.
Parasite samples and DNA sequencing. We generated new full-length mitogenome sequences from 380 
parasite isolates collected between 2001 and 2013, comprising 244 (64.2%) P. falciparum isolates (147 from Brazil, 
21 from Venezuela, 6 from Panama, 27 from Tanzania, 20 from Indonesia, and 23 from Papua New Guinea), 127 
(33.4%) P. vivax isolates (77 from Brazil, 32 from Panama, and 52 from Papua New Guinea), and 9 (2.4%) isolates 
of the P. vivax-like monkey parasite P. simium from the Atlantic Forest of South and Southeast Brazil.
DNA templates were prepared from 200 µL of whole blood samples using QIAamp DNA Blood Mini Kits 
(Qiagen, Hilden, Germany). We designed primer pairs to amplify overlapping fragments of the mitogenomes 
of P. falciparum, P. vivax, and P. simium; primer sequences are given in Supplementary Table 16. Long-range, 
high-fidelity PCR amplification (amplicon size range, 1147–3497 bp) was performed using PrimeSTAR DNA 
polymerase (Takara, Otsu, Shiga, Japan), which has efficient 3′ → 5′ exonuclease proof-reading activity. PCR was 
performed for all species in 100-μl total reaction volume containing 6 μl of DNA template, 0.3 μM concentrations 
of each oligonucleotide primer, 10× PrimeSTAR PCR Buffer, 2.5 mM concentrations of each deoxynucleoside 
(dNTP), and 2.5 units of PrimeSTAR DNA polymerase. PCR was performed on a GeneAmp PCR 9700 thermal 
cycler (Applied Biosystems, Foster City, CA) at 94 °C for 1 min, followed by 30 cycles of 98 °C for 10 sec, 55 °C 
for 5 sec, and 72 °C for 2 min. A final extension was done at 72 °C for 10 min. PCR products were purified with 
an Illustra GFX PCR and Gel Band Purification kit (GE Healthcare Biosciences, Pittsburgh, PA) and sequenced 
using the BigDye kit version 3.1 on an ABI 3130 DNA sequencer (Applied Biosystems, Foster City, CA). We used 
13 internal oligonucleotide primer pairs to sequence both strands of each P. falciparum and P. vivax amplicon 
with reads ranging between 450 bp and 530 bp (P. falciparum) and 303 bp and 566 bp (P. vivax). The P. simium 
mitogenomes were amplified and sequenced with the P. vivax primer set and an additional set of five external and 
10 internal primer pairs that were designed to match the only publicly available P. simium mitogenome sequence, 
which was derived from the Fonseca MRA-353 isolate55 (accession number, AY722798). All fragments ampli-
fied with either primer set were sequenced. Nucleotide ambiguities were removed by further confirming some 
sequences on two independent PCR reactions on the same DNA template. The sequenced fragments were filtered 
for quality and assembled into complete mitochondrial sequences (length, 5,884 bp for P. falciparum and 5,990 bp 
for P. vivax/P. simium) using the phred/phrap/consed software (http://www.phrap.org/phredphrapconsed.htm) 
and deposited in the GenBank database under accession numbers KY923289-KY923647.
Plasmodium falciparum mitogenomes assembled from short sequence reads. We used pub-
licly available whole-genome paired-end Illumina reads generated from P. falciparum isolates from AFR60,61 
and SEA60 with known geographic origin were known (total of 925 short-read data sets) that were retrieved 
from the European Nucleotide Archive (ENA) of the European Molecular Biology Laboratory (EMBL) (acces-
sion numbers, ERS010434-ERS010659 and ERS041968-ERS041991). Sequence reads (average size, 100 bp) that 
mapped onto the mitochondrial DNA of the 3D7 reference strain (accession number, AY282930) were identified 
using BLASTN (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and filtered using the fastq_quality_filter software of 
the FastX-Toolkit package (http://hannonlab.cshl.edu/fastx_toolkit/index.html); only reads with quality scores 
≥15 in every nucleotide were further considered. Mitogenomes were assembled using GS Assembler software 
(Newbler) version 2.7 with a minimum level of coverage of 10 × (average coverage of 200×) for each nucleotide. 
These sequence reads have a potential issue with mixed infections, as they come from clinical isolates that may 
comprise multiple genetically distinct clones. There is therefore a risk of misassembling several different mito-
chondrial sequences into a single hybrid mitogenome. To prevent this, we first converted heterozygote calls to the 
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majority allele if ≥75% of the reads in that sample were the majority allele (i.e., when the dominant clone could be 
clearly defined); otherwise, the sample was excluded from further analysis. Next, all P. falciparum mitogenomes 
retrieved from short sequence reads were analyzed for missassembling that could simulate historical recombi-
nation events. For this purpose, we applied five non-parametric recombination detection methods (MAXCHI, 
CHIMAERA, GENECONV, BOOTSCAN, and SISCAN) with their default parameters; they were implemented 
in the RPD3 computer program62. None of the methods revealed statistical evidence of recombination in any 
assembled mitogenome. Of the 925 short-read data sets retrieved from ENA, 812 (87.8%) generated mitogenome 
assemblings that were used in further analyses.
Sources of additional mitogenomes. We additionally analyzed 739 complete or nearly complete P. fal-
ciparum mitogenomes deposited in the GenBank database from isolates from AFR, Americas, South Asia, SEA, 
and MEL (accession numbers, AY283018–AY282924; AB570434–AB570542; AB570544–AB570765, AB570767–
AB570951; KJ569502–KJ569459; AJ276845–AJ276847; and KT119847–KT119883), 822 P. vivax complete or 
nearly complete mitogenomes from Africa, Americas, MCA, South Asia, SEA, EAS, and MEL (accession num-
bers, AY791517–AY791692, AY598035–AY598140, AB550270–AB550280, JN788737–JN788776, DQ396547–
DQ396548, KC330370–KC330678, JQ240429–JQ240331, KF668442–KF668430, and KF668429–KF668361), and 
a single complete P. simium mitogenome from Brazil (accession number, AY722798). The final data set comprised 
1,795 mitogenomes of P. falciparum, 931 of P. vivax, and 10 of P. simium that were aligned using MEGA version 
6.063 and edited by hand. Gap stripping left 5,775 sites analyzable in the P. falciparum alignment and 5,812 sites 
in the P. vivax/P. simium alignment. Supplementary Database 1 gives a list of all sequences analyzed in this study, 
along with their countries of origin and GenBank accession numbers, and Supplementary Fig. 2 shows the geo-
graphic locations of the SAM and CAM sample collection sites.
Within-population diversity and between-population divergence. We used DnaSP software 
version 564 to calculate the haplotype diversity (H), the standardized number of segregating sites, θS65, and the 
average number of pairwise nucleotide differences per site, π66, which was calculated with the Jukes-Cantor’s 
correction. Arlequin software version 3.567 was used to carry out Tajima’s68 and Fu’s Fs69 neutrality tests, which 
detect deviations from a neutral evolution model that assumes random mating, no recombination, mutation-drift 
equilibrium, infinite sites, and constant population size. The statistical significance of both tests was examined 
using 1,000 coalescent simulations under a standard model of neutral evolution. A P value of 0.02 for Fu’s Fs test 
obtained from coalescent simulations corresponds to the conventional P value of 0.0569; therefore, Fu’s Fs test 
results were considered significant if they were associated with a P value < 0.02.
We also used Arlequin 3.5 software to estimate the Wright’s fixation index FST, a measure of divergence between 
populations due to genetic structure70. Significance was evaluated using one-sided permutation tests with 1,000 
simulations. The following regional populations were considered in FST calculations: AFR, SAM, CAM (including 
Mexico in P. vivax analyses; CAM), MCA; only for P. vivax, SOA, SEA, EAS (only for P. vivax), and MEL.
Phylogeny and historical demography. Bayesian phylogenetic analysis was carried out separately for P. 
falciparum and P. vivax/P. simium using MrBayes version 3.2.171 with two runs of four chains each, three heated 
and one cold, for seven million (P. vivax) or 10 million generations (P. falciparum). The trees were drawn using 
Dendroscope version 3.4 software72, and a color code was used to identify the geographic origin of parasites: AFR 
(red), SAM (dark blue), CAM (light blue), Atlantic Forest from southeast Brazil (ATL [yellow]; only for P. vivax/P. 
simium); MCA ([brown]; only for P. vivax), SOA (orange), SEA (green), EAS ([dark purple]; only for P. vivax), 
and MEL (pink).
Median-joining phylogenies73 were generated using Network version 4.6 (Fluxus Technologies, http://www.
fluxu-engeneering.com) with the default parameters and transversions weighted twice as much as transitions. 
This analysis aimed to reconstruct global haplotype networks of the entire sets of P. falciparum and P. vivax/P. 
simium mitogenomes, and the same color code described above was used to show the geographic origins of sam-
ples. Straight lines connect pairs of haplotypes that differ by a single mutational step. Separate haplotype networks 
were also generated for parasites from the Americas to further explore regional patterns of genetic variation.
We used Arlequin 3.5 to obtain frequency distributions of pairwise mismatches between mitochondrial 
sequences to explore the demographic history of parasite populations. Multimodal, ragged distributions are 
expected under constant population size, whereas unimodal distributions are typically observed in expanding 
populations. Separate analyses were carried out for parasites from AFR, SAM (comprising ATL), CAM, MCA 
(only for P. vivax), SOA, SEA, EAS (only for P. vivax), and MEL. We also separately analyzed country-level par-
asite populations from the Americas (Brazil and Venezuela for P. falciparum; Brazil, Colombia, and Peru for P. 
vivax). We calculated the sum of square deviations (SDD) and the raggedness index (R) to compare observed 
mismatch distributions with those expected under a sudden demographic expansion model74. These analyses 
were carried out using the pegas package of R software version 3.3.0 with 1,000 pseudoreplicates.
Next, we used the Markov chain Monte Carlo (MCMC) method implemented in BEAST software version 1.7.275 
to fit Bayesian skyline coalescent models that allowed us to track changes in Ne over time and estimate the time 
TMRCA of mitochondrial lineages. Separate analyses were run for the global population of each species and for the 
following regional populations: AFR, SAM (comprising ATL), CAM (only for P. vivax), MCA (only for P. vivax), 
SOA, SEA, EAS (only for P. vivax), and MEL. A Hasegawa-Kishino-Yano (HKY) nucleotide substitution model was 
used. Analyses were run for 200 million generations; the first 20,000 generations were discarded as burn-in, and 
sampling was performed every 5,000 generations. We used a strict molecular clock with 12 × 10−9 substitutions 
per site per year as the average nucleotide substitution rate for mitogenomes of malaria parasites, derived from a 
comparison of the rate for cytochrome b evolution in avian malaria parasites relative to its rate in bird hosts, for 
which dated fossils are available76. Note that this nucleotide substitution rate is substantially (1.5 to 4 times) faster 
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than previous estimates based on assumed host-parasite co-speciation events14,77. In addition, a quite recently pub-
lished analysis estimates mitochondrial nucleotide substitution rates at 3.8 × 10−9 substitutions per site per year for 
mammalian malaria parasites78. We therefore note that parasite lineages currently found in the Americas may be 
up to four times older than estimated here, depending on the molecular clock used. BEAST outputs were visualized 
with Tracer version 1.5 software79. We used TreeAnnotator version 2.1.279 to obtain consensus trees derived from the 
skyline analyses after discarding the first 20,000 trees as burn-in. TMRCA estimates (with 95% HPD intervals) were 
obtained for the branches with a posterior probability >0.70 in the consensus trees. The topology of these consensus 
trees was remarkably similar to that of the Bayesian phylogenetic trees generated by MrBayes.
Parasite migration models. MIGRATE-N version 3.6.11 software29 was used to compare parasite migra-
tion models and make inferences regarding the sources of malaria parasites currently found in the Americas. 
MIGRATE-N uses MCMC simulations to sample possible coalescent genealogies and to estimate, using a 
Bayesian approach, two sets of parameters: (a) mutation-scaled effective population sizes (θ = 4Νeμ, where Ne 
is the effective population size and μ is the mutation rate) and (b) mutation-scaled pairwise migration rates 
(M = m/μ, where m is the migration rate). MIGRATE-N also provides the marginal likelihood of each migration 
model. The underlying coalescent model assumes neutral evolution, constant migration rates and population 
sizes over Ne generations (in haploid organisms) and that all potential source populations have been sampled80. 
Log marginal likelihoods (log mL) calculated by thermodynamic integration with Bézier approximation81 were 
used to rank models.
We compared 8 a priori models for P. falciparum that differ in the presence and directionality of gene flow 
between particular pairs of populations (Supplementary Fig. 12). Model A assumes an African origin of P. fal-
ciparum33 and its subsequent unidirectional, eastward spread out of Africa, first to South Asia and then to SEA 
and MEL24,82. This parasite is assumed to have been introduced separately into the Americas (SAM and CAM 
combined) from the AFR population2,8. The next model (A1) is identical to A, but it assumes a bidirectional flow 
between AFR and SOA populations. The next six models (B, B1, C, C1, D, and D1) assume additional contribu-
tions of either SOA, SEA, or MEL to the extant diversity of New World P. falciparum populations.
Likewise, we compared 11 different P. vivax models assuming an African origin of P. vivax46. As with P. falci-
parum, model A assumes a stepwise out-of-AFR spread to the Old World and a separate migration of the AFR 
population to the Americas (SAM and CAM combined; Supplementary Fig. 13). Model A1 assumes a bidirec-
tional gene flow between AFR and the MCA and SOA populations (the latter two merged into a single population, 
SOA*) under the hypothesis that some major P. vivax lineages currently found in AFR have been reintroduced 
to this continent from these sources3,26. The next eight models (B, B1, C, C1, D, D1, E, and E1) assume additional 
gene flow to the New World from either SOA*, SEA, EAS, or MEL3,15,16,28,58. Finally, model F allows for a unilateral 
gene flow from SOA* and MEL populations to the Americas with bilateral gene flow between AFR and SOA*.
Next, we compared six models under an alternative scenario that assumes a Southeast Asian (instead of 
African) origin of P. vivax28,31 (Supplementary Fig. 14). The basic model A assumes a unidirectional eastward 
gene flow to EAS and MEL and a stepwise gene flow westward to South Asia, Africa, and the Americas. The next 
four models (B, C, D, and E) assume additional gene flow to the New World from either MEL, SOA*, SEA, or 
EAS, whereas model F assumes additional gene flow from both SOA* and MEL populations to the Americas.
For each P. falciparum migration model, we ran two replicates of four parallel static chains with temperatures 
of 1.0, 1.5, 3.0 and 106 and a swapping interval of 1. We used uniform priors between 0 and 0.15 (delta = 0.013) for 
θ and between 0 and 30,000 (delta = 3,000) for M. In each run, we discarded 30,000 trees as burn-in and recorded 
5 × 106 steps with an increment of 10. P. vivax models were run with similar settings, except that M priors ranged 
between 0 and 20,000 (delta = 2,000). We assessed model convergence by examining the posterior distributions 
of the parameters to determine whether they were unimodal with smooth curves. Natural log Bayes factors (LBF) 
were calculated as a ratio of the marginal likelihoods to calculate probabilities of each model. LBF <−2 indicate 
a strong preference for the best-supported model.
Data availability statement. All data used in the current analyses have been deposited into public 
databases.
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